Key result
Antihypertensive treatment or discharge prescription cuts 30-day ED revisits ~39% in hypertensive urgency.
Why the study?
Patients discharged after management of severely elevated blood pressure without acute target-organ damage often experience poor control and unplanned health-care use. This review examined factors associated with treatment failure and recurrent uncontrolled blood pressure after discharge, distinguishing them from true rebound hypertension caused by abrupt antihypertensive withdrawal.
Systematic Review
In patients discharged after hypertensive urgency, receiving treatment during the index visit or a discharge antihypertensive prescription is associated with fewer 30- to 60-day emergency department revisits, whereas the incidence of true rebound hypertension remains unestablished.
Answers are grounded in this paper and cite their sources.
Antihypertensive prescription at discharge may lower 30-day revisits after hypertensive urgency; extends limited observational data but leaves practice change open.
Introduction: Severely elevated blood pressure without acute target-organ damage is commonly managed outside the hospital, but poor control and unplanned health[1]care use remain concerns after discharge. This review examined factors associated with treatment failure and recurrent uncontrolled blood pressure after discharge and distinguished them from true rebound hypertension caused by abrupt antihypertensive withdrawal. Methods: PubMed and ScienceDirect were searched for studies published from January 2021 through 26 August 2026 in accordance with PRISMA 2020. Two reviewers independently screened records, assessed full-text eligibility, extracted data, and appraised study quality. Disagreements were resolved by consensus. Owing to substantial heterogeneity, findings were synthesized narratively without statistical pooling. Results: Nine observational studies and one uncontrolled pilot pathway study were included, with sample adherence was associated with hypertensive crisis, although measurement methods varied. In two large retrospective emergency-department cohorts, treatment during the index visit or an antihypertensive prescription at discharge was associated with fewer 30- or 60-day revisits. One study reported an adjusted odds ratio of 0.610 (95% confidence interval, 0.547–0.678) for a 30-day revisit. Discharge blood pressure alone was not consistently associated with short-term major cardiovascular events. No included study established the incidence of true rebound hypertension after discharge. Conclusion: Available evidence does not support a pooled incidence of rebound hypertension or a causal ranking of associated factors. Medication reconciliation, adherence assessment, appropriate long-acting therapy, and reliable outpatient follow[1]up are clinically reasonable. ABSTRAK Pendahuluan: Hipertensi berat tanpa kerusakan organ target akut umumnya ditangani di luar rumah sakit,tetapi pengendalian yang buruk dan penggunaan layanankesehatan yang tidak terencana tetap menjadi perhatian setelah pemulangan. Tinjauan ini menganalisis faktor yang berhubungan dengan kegagalan terapi dan kekambuhan tekanan darah tidak terkontrol serta membedakannya dari hipertensi rebound sejati akibat penghentian antihipertensi secara mendadak. Metode: PubMed dan ScienceDirect ditelusuri untuk studi yang diterbitkan sejak Januari 2021 hingga 26 Agustus 2026 sesuai PRISMA 2020. Dua penelaah secara independen melakukan skrining, menilai kelayakan teks secara menyeluruh, mengekstraksi data, dan menilai kualitas studi. Perbedaan diselesaikan melalui konsensus. Heterogenitas yang substansial menyebabkan hasil disintesis secara naratif tanpa penggabungan statistik. Hasil: Sembilan studi observasional dan satu studi percontohan tanpa kelompok kontrol disertakan, dengan ukuran sampel 40–129.239 peserta. Ketidakpatuhan pengobatan berhubungan dengan krisis hipertensi, tetapi metode pengukurannya bervariasi. Pada dua kohort retrospektif besar di instalasi gawat darurat, terapi saat kunjungan indeks atau peresepan antihipertensi saat pemulangan berhubungan dengan lebih sedikit kunjungan ulang dalam 30 atau 60 hari. Satu studi melaporkan rasio odds tersesuaikan 0,610 (interval kepercayaan 95%: 0,547–0,678) untuk kunjungan ulang pada hari ke-30. Tekanan darah saat pemulanganyang tidak konsisten berhubungan dengan kejadian kardiovaskular mayor dalam jangka pendek. Tidak ada studi yang menetapkan insiden hipertensi rebound sejati setelah pemulangan. Simpulan: Bukti yang tersedia tidak mendukung estimasi insiden gabungan hipertensi rebound atau peringkat kausal dari faktor terkait. Rekonsiliasi obat, penilaian kepatuhan, terapi kerja panjang yang sesuai, dan tindak lanjut rawat jalan secara klinis wajar.
No takes yet. Share an insight, caveat, or question.
Setyawan et al. (2026) conducted a systematic review in Hypertensive urgency / severely elevated blood pressure without acute target-organ damage. Treatment during index visit or antihypertensive prescription at discharge vs. No treatment during index visit or no prescription at discharge was evaluated on 30-day emergency department revisit (OR 0.610, 95% CI 0.547-0.678). Index visit treatment or discharge antihypertensive prescription reduced 30-day emergency department revisits in patients discharged with hypertensive urgency.
Synapse has enriched 10 related papers. Consider them for comparative context: